Gerard Zitnik
Director, Worldwide Medical Neuroscience Bristol Myers Squibb
Seminars
Thursday 17th September 2026
Beyond Psychosis: Expanding Muscarinic Biology Across Schizophrenia, Bipolar Disorder & Alzheimer’s Disease
3:00 pm
- Insights from long‑term and post‑approval data on real‑world use and safety in schizophrenia
- Ongoing efforts to clarify muscarinic mechanisms and their impact on cognition, negative symptoms, and functional outcomes
- Scientific rationale and development considerations for expanding muscarinic therapies into bipolar disorder and Alzheimer’s disease
